Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Recruiting 28Unknown 25Not yet recruiting 13Completed 8Terminated 5Withdrawn 3Active not recruiting 3Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Lymphoma, B-Cell 2Colorectal Neoplasms 2Pancreatic Ductal Adenocarcinoma 1Ototoxicity 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Leukemia, B-Cell 1Hepatoblastoma 1Depression 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Suspended × Multiple Myeloma × Clear all
NCT06663046 2026-05-07

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Wondercel Biotech (ShenZhen)

Phase EARLY_PHASE1 Suspended
30 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡